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Introduction:
Tuberculosis (TB) is one of the world's deadliest diseases and is caused by Mycobacterium tuberculosis, which has a single known host (man) [1, 2] . The air-borne nature of this bacterium makes the disease highly infectious, and the World Health Organization (WHO) has reported that one third of the world's population is probably infected with latent TB, and that there is a new case every second [3] . The mycobacterial cell wall has a complex structure made up of lipids, glycolipids, polysaccharides and proteins [4] . There has been growing interest in the construction of Darabinooligosaccharides related to mycobacterial cell wall components, arabino-galactan, lipoarabinomannan and arabinomannan from M. tuberculosis [5] . The mycolylarabinogalactan (mAG) complex is the largest component structure and forms from cross bonding between both Darabinofuranosyl (Araf) and galactofuranosyl (Galf) with a long-chain α-alkyl-branched β-hydroxylated fatty acid, 'mycolic acid' (MA) [6] . The complex lipids and polysaccharides within the cell wall of M. tuberculosis are assumed to be the cause of its characteristic pathogenesis [7] . Anderson and Geiger in 1937 reported the first extraction of arabino-mycolate from the cell wall of Mycobacterium bovis using organic solvent [8] . Azuma et al. reported the isolation of arabinose mycolate under acidic conditions [9] . The structure of the mycolyl-arabinogalactan complex of M. tuberculosis was reinterpreted using mass spectrometry and NMR spectroscopy [10, 11] . Synthetic arabinofuranosyl oligosaccharides, including a branched pentasaccharide were reported in 1998 [12, 13] . In 2005, the preparation of a tetramycolylpentaarabinose (1) (Fig. 1 ) using a complex natural mixture of MAs was described [14] . However, only in 2010 were structural studies of the composition of the arabinose mycolates of the cell wall of M. bovis reported [15] . Ishiwata et al. reported the synthesis of a series of mono-(3), di-and tetra-arabinomycolates (1) found at the terminal position of the cell wall skeleton of BCG from M. bovis, using natural MA mixtures extracted from cells. All of the compounds showed strong TNF-α inducing activity in vitro. Such arabinose mycolates have also been reported to show anti-cancer properties [6] . The mechanism of the activity of arabinomycolates is not clear [14] . Although a methoxy trisaccharide of arabinofuranose 2 ( Fig. 1) has been prepared and used in an acylation reaction with fatty acids such as behenic acid, palmitic acid and butyric acid [16] , there are no examples of the synthesis of arabinofuranose oligosaccharides esterified with structurally defined complete synthetic mycolic acids (MAs) which are the main components of the cell wall of M. tuberculosis [6] . MAs 4 are β-hydroxy fatty acids with a long α-alkyl side chain ( Fig. 2) [17, 18] . [19, 20] . Natural mixtures extracted from mycobacteria consist of many individual MA containing a range of functional groups, X and Y, including cis-and trans-cyclopropanes, cis-and transalkenes, methoxy and keto fragments, and different chain lengths [21] .
The aim of this study was to synthesize a series of dimycolated triarabinoses (2), comprising single defined synthetic mycolic acids, in order that the selectivity of their immune stimulatory activity, e.g. in inducing Interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), could be evaluated.
Results and Discussion

Synthesis of Trisaccharides
The target trisaccharide structure 2 has two α-glycosidic linkages, which can be assembled readily from known building blocks, donor 5 [22] and acceptor 6 [23] . The route to the 2,3-O-benzoyl-protected thioglycosyl donor 5 was slightly modified compared to the literature method (Scheme 1) [22] . D-(-)-Arabinose was treated with HCl, freshly prepared by addition of acetyl chloride to anhydrous methanol at 0 ºC. Work up with pyridine rather than ammonium carbonate [24] , gave methyl-α, β-D-Araf, 7 (R = H), with predominant formation of the αanomer (α/β-D, 3:2) [25, 26] . Rather than esterifying with benzoate, the mixture was directly esterified to give triacetate 7 (R = Ac) [22] . Condensation of this with p-thiotoluene in the presence of boron trifluoride etherate afforded 8 (R = Ac), which on reaction with NaOCH3 in methanol afforded thioglycoside triol 8 (R = H). Protection of the primary alcohol as a silyl ether followed by benzoylation of the secondary alcohols gave 5. The initial step in the synthetic route to acceptor 6 [23] , the separation of the two anomers of 7 (R = H), was carried out using two methods (Supplementary data, Schemes 1 and 2).
Liu et al. [16] have reported the coupling of the monosaccharide building blocks to prepare the trisaccharide through the reaction of a 2-O-benzylated glycosyl acceptor and thioglycoside 5 using silver trifluoromethane sulfonate and Niodosuccinimide in dry CH2Cl2. In the present work, the benzoylated glycosyl acceptor 6 and thioglycoside 5 were reacted under the reported conditions (Scheme 2). Trisaccharide 9a was obtained as a single stereoisomer in 87% yield, which is similar to that reported for the benzyl compound [16] . The product showed the expected three acetal signals in the proton NMR spectrum, two broad singlets at δ 5.10 and 5.33, for the newly formed α-glycosidic links, and a third singlet at 5.56; these correlated by HSQC with three signals in the carbon spectrum for the glycosidic links at δ 107.0, 106.0 and 105.3 respectively. Compound 9a was deprotected with sodium methoxide to give 9b as a thick oil in 81% yield. This was benzylated to protect the five secondary hydroxyl groups using benzyl bromide and sodium hydride in dry DMF to give 9c. Desilylation of the two primary hydroxyl groups gave 10a. Direct esterification of the primary hydroxyl group of Araf with a carboxyl group in natural mycolic acid mixtures has been achieved in a low yield (30%) [14] , while activating the sugar as a tosylate raised the yield to 79%. Therefore, the two hydroxyl groups in compound 10a were tosylated using p-toluenesulfonyl chloride in dry pyridine in the presence of catalytic 4dimethylaminopyridine to afford the tosylate 10b (Scheme 2). The next step was the coupling of trisaccharide 10b with the structurally defined synthetic mycolic acids, which had been prepared earlier [27] [28] [29] . Firstly, a model tri-arabinodi mycolate was prepared by coupling tosylate 10b with palmitic acid through the alkylative esterification strategy using cesium hydrogen carbonate in dry DMF: THF at 70 ºC for four days [14] , to give compound 11a, which was then debenzylated to give compound 12a (Scheme 3). The synthesis of this glycolipid has been reported using a different method. Data obtained for 12a was identical to that reported [16] .
A series of triarabino-dimycolates were then prepared according to the above procedure; the structures of the mycolic acid moieties, including α-, methoxy-and ketoclasses are shown in Scheme 3. In each case, the products the proton NMR spectra included the expected three characteristic broad single-hydrogen singlets for the acetal hydrogens in the region δ 4.9 -5.2.
IL-6 and TNF-α secretion assays with the synthesized compounds
Ishiwata et al. reported the synthesis of a series of mono-, diand tetra-arabinomycolates found in the terminal position of the cell-wall skeleton of bacillus calmette Guerin from M. bovis, by using natural mycolic acid mixtures extracted from the cell wall and showed they differentially induce TNF-α secretion in a murine macrophage cell line, some at levels similar to trehalose dimycolate (TDM) [14] . Arabinomycolates obtained by acid hydrolysis from the originally prepared CWS (SMP-105) of M. bovis BCG Tokyo 172, consisting mainly of mono-arabinose mono-mycolate, pentaarabinose tetra-mycolate and hexaarabinose tetra-mycolate fractions, significantly induced TNF-α production with an intensity comparable to that of cell-wall skeleton, a potent adjuvant, and enhanced delayed type per sensitivity reactions against inactivated tumour cells. The induced TNF-α production was completely dependent on TLR2 and MyD88 pathways [6] . To provide an initial evaluation of the activities of synthesised tri-arabino di-mycolates reported here (12c and 12f) as immune potentiators, secretion inducing assays for IL6 and TNF-α, cytokines involved in inflammation, were conducted, in comparison with TDM and synthetic monoarabino mono-mycolates [30] . Surprisingly, neither compound was strongly stimulatory in either assay when compared to synthetic TDMs, trehalose monomycolates or arabinose mycolates [31, 32] . Further work to evaluate the biological effects of these molecules is under way.
Experimental Section
For general experimental detail, see Supplementary Information. Unless otherwise stated, all products were single components by TLC and by proton and carbon NMR.
3.1:
(a) Molecular sieves 4 Å (6.6 g) were added to a stirred solution of the acceptor 6 (0.9 g, 3.3 mmol) and the donor 5 (6.0 g, 8.5 mmol) in dry CH2Cl2 (30 mL) at r.t. under a nitrogen atmosphere. The reaction mixture was stirred for 30 min. then cooled to -60 ºC and N-iodosuccinimide (2.09 g, 9.29 mmol) was added followed by the addition of AgOTf (0.36 g, 1.40 mmol). The mixture was stirred at the same temperature until the color became red/dark brown and TLC showed no starting material, then it was quenched by the addition of triethylamine (1 mL) until it turned yellow. The mixture was diluted with CH2Cl2 (100 mL) and filtered through celite and the solvent was evaporated under reduced pressure. Column chromatography on silica eluting with hexane/ethyl acetate (5:1 
3.3: Methyl 5-O-(2-[(R)-1-hydroxy-18-[(1R,2S)-2-[(17S, 18S)-17-methoxy-18methylhexatriacontyl]cyclopropyl]octadecyl]-tetracosanoate)-
α-D-arabino-furanosyl-(1→3)[5-O-(2-[(R)-1-hydroxy-18- [(1R,2S)-2-[(17S,18S)-17methoxy-18-methyl- hexatriacontyl]cyclopropyl]octadecyl]tetracosanoate)-α-D- arabinofuranos-yl-(1→5)]-α-D-Araf 12c (a)
3.4: Methyl 5-O-(2-[(R)-1-hydroxy-12-{(1R,2S)-2-(14-[(1R, 2S)-2-eicosylcyclopropyl]tetradecyl]cyclopropyl}dodecyl)hexacosanoate)-α-D-arabinofuranosyl-(1→3)-[5-O-(2-[(R)1-hydroxy-12-{(1R,2S)-2-(14-[(1R,2S)-2-eicosylcyclopropyl]tetradecyl]cyclopropyl}dodecyl)hexacosanoate )-α-Darabinofuranosyl-(1→5)]-α-D-Araf 12d (a)
Cesium hydrogencarbonate (0.089 g, 0.458 mmol) was added to a stirred solution of 10b (0.055 g, 0. 
